Bionano Genomics, Inc.
BNGO Nasdaq
SEC CIK 1411690
Follow Bionano Genomics
Weekly email: filings, results
Revenue, last quarter
$8.3M
+12.3% vs same quarter last year
Net income
−$6.5M
+24.1% vs same quarter last year
EPS, diluted
−$0.54
+66% vs same quarter last year
Operating cash flow
−$4.5M
+23.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $28.5M | −$26.4M |
| FY24 | $30.8M | −$112M |
| FY23 | $36.1M | −$232.5M |
| FY22 | $27.8M | −$132.6M |
| FY21 | $18M | −$72.4M |
| FY20 | $8.5M | −$41.1M |
| FY19 | $10.1M | −$29.8M |
| FY18 | $12M | −$18.5M |
| FY17 | $9.5M | −$23.4M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 46.3% | −116.9% | −92.6% |
| FY24 | 1.2% | −337.9% | −364% |
| FY23 | 26.5% | −596% | −643.7% |
| FY22 | 21.4% | −473.7% | −476.9% |
| FY21 | 21.5% | −428.8% | −402.8% |
| FY20 | 32.6% | −453.4% | −483.4% |
| FY19 | 33.2% | −255.4% | −294.3% |
| FY18 | 27.4% | −170.1% | −154.1% |
| FY17 | 36.6% | −244.3% | −245.8% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | −$38.3M |
| FY19 | −$29.6M |
| FY18 | −$20.3M |
| FY17 | −$21.8M |
| FY16 | - |
- Bionano Genomics
- Technology median
Show the numbers
| Year | Bionano Genomics | Technology median |
|---|---|---|
| FY25 | −92.6% | −2.4% |
| FY24 | −364% | −5% |
| FY23 | −643.7% | −6.7% |
| FY22 | −476.9% | −4.4% |
| FY21 | −402.8% | −1.7% |
| FY20 | −483.4% | −3% |
| FY19 | −294.3% | 0% |
| FY18 | −154.1% | 0.8% |
| FY17 | −245.8% | 2% |
| FY16 | - | 2.3% |